Diamond Weave

In recent years, IV drug distribution has been a dynamic and ever-changing environment. Challenges faced by hospital pharmacy managers and directors have included supply disruptions,1 staffing shorages,2 rising costs,3 safety concerns,4 absence of standardization,4 and inefficiencies that have resulted in large-scale drug waste.5

This is intended for U.S. healthcare professionals only.

Rx Only.

Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction and Operational Efficiency in IV Medication Distribution

This Special Report, we will discuss:

Read time :  clock 3 minutes

Factors that can affect quality IV drug distribution.The factors that can affect quality IV drug distribution

Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction Operational Efficiency in IV Medication Distribution How point-of-care admixture practices may impact drug delivery times, optimize automated dispensing cabinets, reduce drug and labor waste, and improve flexibility to navigate shortages

 

 Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction and Operational Efficiency in IV Medication Distribution

References:

  1. Fox ER, Mclaughlin MM. ASHP guidelines on managing drug production shortages AM J Health Syst Pharma. 2018;75(21):1742-1750.
  2. American Society of Health-System Pharmacists. Pharmacy technician shortages survey findings. Executive summary. Accessed February 23, 2023. https://www.ashp.org/-/media/assets/pharmacy-technician/docs/Technician-Shortages-Survey-Exec-Summary.pdf
  3. Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017; 6:37-46.
  4. Cohen MR, Smetzer JL, Vaida AJ. ASHP guidelines on preventing medication errors In hospitals: advancing medication safety to the next level. AM J Health Syst Pharm. 2018;75(19):1444-1445.
  5. Bekker CL, Gardarsdottir H, Egberts ACG, et al. Pharmacists’ activities to reduce medication waste: an international survey. Pharmacy (Basel). 2018;6(3):94.

 

Captcha

Captcha

The Vial2Bag Advanced® 13mm and 20mm admixture devices are 510(k) cleared by the United States Food and Drug Administration (FDA). The use of the Vial2Bag Advanced® 13mm and 20mm admixture devices should not be interpreted as modifying, extending, or superseding a drug manufacturer's labeling recommendations for storage and expiration dating, unless otherwise limited by USP <797> compounding standards. Refer to drug manufacturer's labeling and use instructions for recommendations, USP <797>, and applicable institution policy for shelf life and sterility information of reconstituted product and admixture device compatibility. Compatibility of the Vial2Bag Advanced® 13mm and 20mm admixture devices with all drug products has not been confirmed. Do not use the Vial2Bag Advanced® 13mm and 20mm admixture devices with lipids. Failure to follow the instructions provided may result in inadequate medication reconstitution, dilution, and/or transfer, possibly leading to overdose or underdose and/or delay in therapy. Products shown are for INFORMATION purposes only and may not be approved for marketing in specific regions. Please contact your West Pharmaceutical Services, Inc. (West) representative for product availability.

Vial2Bag Advanced® 20mm Admixture Device: Cost Reduction and Operational Efficiency in IV Medication Distribution